ResearcherInstitut d'Investigació Biomédica de BellvitgeNo recent work listed
Josep Maria Borràs
Matched on ORCID iD 0000-0001-7330-6308; OpenAlex author ID A5031850765. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 21
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 5
- Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia. Last author DOI 10.3390/ijerph20095673↗
- Centralisation of surgery for complex cancer diseases: A scoping review of the evidence base on pancreatic cancer. Last author DOI 10.1016/j.jcpo.2022.100334↗
- Bratislava Statement: consensus recommendations for improving pancreatic cancer care. Last author DOI 10.1136/esmoopen-2020-001051↗
- Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. Co-author DOI 10.1245/s10434-018-6705-1↗
- Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. Co-author DOI 10.1016/j.ejso.2016.03.011↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paula Manchon‐Walsh · 2 shared papers, 2022–2023 · strength 0.43
- Joan Prades · 2 shared papers, 2020–2022 · strength 0.31
- Cristina Coll-Ortega · 2 shared papers, 2020–2022 · strength 0.31
- Laura Guarga · 1 shared paper, 2023 · strength 0.20
- Babs G. Sibinga Mulder · 2 shared papers, 2016–2018 · strength 0.12
- Paper Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. DOI 10.1245/s10434-018-6705-1↗
- Paper Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. DOI 10.1016/j.ejso.2016.03.011↗
- Bert A. Bonsing · 2 shared papers, 2016–2018 · strength 0.12
- Paper Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. DOI 10.1245/s10434-018-6705-1↗
- Paper Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. DOI 10.1016/j.ejso.2016.03.011↗
- J. Sven D. Mieog · 2 shared papers, 2016–2018 · strength 0.12
- Paper Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. DOI 10.1245/s10434-018-6705-1↗
- Paper Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. DOI 10.1016/j.ejso.2016.03.011↗
- Stefano Partelli · 1 shared paper, 2020 · strength 0.08
- Božena Smolková · 1 shared paper, 2020 · strength 0.08
- Thomas Baptist Brunner · 1 shared paper, 2020 · strength 0.08
- Francesco Sclafani · 1 shared paper, 2020 · strength 0.08
- Dirk Arnold · 1 shared paper, 2020 · strength 0.08
- Núria Malats · 1 shared paper, 2020 · strength 0.08
- Alfredo Carrato · 1 shared paper, 2020 · strength 0.08
- Giovanni Luigi Capretti · 1 shared paper, 2018 · strength 0.07
- Jesse V. Groen · 1 shared paper, 2018 · strength 0.07
- Lydia G. van der Geest · 1 shared paper, 2018 · strength 0.07
- Emily Leede · 1 shared paper, 2016 · strength 0.05
- Klaus Sahora · 1 shared paper, 2016 · strength 0.05
- V.E.P.P. Lemmens · 1 shared paper, 2016 · strength 0.05
- Michael Bau Mortensen · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.